CRI-CIMT-EATI-AACR - The Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival. The Reference Meeting for Scientists, Clinicians, Regulators, Drug Developers, and Patient Advocates.
With the explosion of interest in cancer immunotherapy and the proliferation of scientific meetings in the field, the time is right for a coordinated effort hosted by the field's leaders. The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) joined forces to sponsor the first International Cancer Immunotherapy Conference. This collaborative meeting will be held every other year, in lieu of each organization's individual meeting, and will alternate between the United States and Europe. By combining efforts the aim was and is to be more effective and efficient in disseminating the latest cutting-edge information.